Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-21-009112

President and CEO sold 778 shares at $7.66 ($5,959)

  • President and CEO acquired 1,785 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shukla Sanjay President and CEO 2021-02-06 Option exercise +1,785 9,076 D
Shukla Sanjay President and CEO 2021-02-09 Sale −778 $7.66 $5,959 8,298 D
Derivatives
Shukla Sanjay President and CEO 2021-02-06 Option exercise · Restricted Stock Unit −1,785 0 D
Open-market sales · 778 sh · avg $7.66 · $5,959
Loading xslF345X03/doc4.xml…